DLRC | Regulatory Affairs Consultancy

We work with clients, who range from Top 5 Pharma companies to SMEs, to develop and execute innovative regulatory strategies from early product development to post-licensing activities for medicines and medical devices.

We pride ourselves on our understanding of clients’ needs and our flexible, creative and pragmatic approach puts our clients and the patients they serve at the centre of everything we do.

DLRC Achieves King’s Award for Enterprise 2024

DLRC Ltd has been honoured with the King’s Award for Enterprise, recognising its outstanding performance in international trade. Formerly known as The Queen’s Awards for Enterprise, the King’s Awards for Enterprise was renamed last year to honour His Majesty The King’s commitment to recognising outstanding UK businesses.

Read the press release

Kings Award for Enterprise in International Trade 2024

Partnership and collaboration

Working in partnership with Pharma, Biotech and MedTech companies, DLRC supports and facilitates the development of new medicines and medical devices to the benefit of patients in Europe, the US and beyond.

Life-cycle product management

From scientific advice in early product development, to clinical trials, marketing authorisation applications and post-licensing activities, our highly qualified and experienced team can maximise value through life-cycle product management and ensure you, as a client make, the best-informed development decisions.

Our Services

A forward-thinking consultancy, DLRC understands individual company’s unique requirements and finds creative and pragmatic solutions for all regulatory challenges.

How can DLRC help you maximise your products’ and company’s potential?

Are you prepared for the new
Clinical Trials Regulation?

The EU Clinical Trials Regulation (CTR) entered into force on 31 January 2022 and is now mandatory for all new applications as of 31 January 2023.

Find out more

Testimonials

See what our clients have to say about DLRC

Thank you so much for your support and for guiding us through the entire process! Especially the last couple of weeks were so intense and have shown how important a well aligned team is! Great job everyone … You were our compass all the time… you were always spot on when needed; and all the time, you gave us the confidence to get where we wanted to be at the end.

We wanted to extend our thanks for all of your hard work, expertise and thoughtful partnership … You have been instrumental in operationalizing … capabilities we have been building together across people, process, tech, and content. We know that it hasn’t been easy at times because we are building something totally new and consider you a great partner to navigate this with. We are really looking forward to our continued work … Thank you!”

I take this opportunity to thank you for your initiative and agility in leading regulatory response and strategy in unexpected circumstances … Your support is indispensable and highly appreciated.

I would like to thank DLRC for the great leadership of the filing team and the fantastic preparation and chairing of the pre-submission meeting with the team and rapporteurs. It is great to have your experience and expertise on board for this important filing. The team managed to get all possible information from the rapporteurs in a fruitful and professional atmosphere, fostering great communication amongst the attendees.

We’d like to acknowledge DLRC for their hard work and ‘whatever it takes’ mindset during the recent project activities they completed for us, including key protocol amendment submissions made across multiple countries.

As a small biotech company with no facilities in Europe, we needed a strong partner to represent us and to support our global initiatives. The team assigned to our program has provided a broad range of regulatory expertise and operational support, and has been thorough, organized, responsive, and a pleasure to work with. The onboarding of the DLRC team was seamless, and they made efforts to familiarize themselves with our product and program right away so that they could contribute to both strategic planning and execution. I look forward to continuing our partnership as we progress our program.